“We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our core ...

Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...

In a significant move to stabilize its operations, 23andMe has announced the layoff of 200 employees, representing a ...

Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to ...

The company said it is evaluating strategic alternatives, including licensing agreements and asset sales, for its therapies ...

As founder and CEO Anne Wojcicki struggles to take the company private, 200 jobs are cut as part of its restructuring plan.

Genetic-testing lab 23andMe plans to cut its workforce by 40% and end its therapeutics program in an effort to cut costs, the ...

The genetics company is closing a unit that was once seen as core to its future.

版权声明：本文版权归FT中文网所有，未经允许任何单位或个人不得转载，复制或以任何其他方式使用本文全部或部分，侵权 ...

American businesswoman Anne Wojcicki is the co-founder and CEO of genetic testing company 23andMe. She became a billionaire after the company went public in 2021 but since then, the company’s ...

Regarding its workforce reduction, which will total 200 employees, CEO Anne Wojcicki called the layoffs a “difficult but necessary” step to keep the company alive. “We are taking these difficult but ...

That request epitomises the fall of a company that transformed its chief executive and founder Anne Wojcicki, ex-wife of Google founder Sergey Brin, into a paper billionaire when it floated three ...